drugset / Trial / NCT00928837

Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee

NCT00928837

Completed 350 enrolled Primus Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to compare the efficacy and safety of flavocoxid (Limbrel) with Naproxen and placebo in OA of the knee.

Timeline

Start
2006-03
Primary completion
2007-06
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule

Indications